Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities
Pharma Penny Stock Under Rs 50: Company Is Establishing A State-Of-The-Art R&D Center In Hyderabad To Enhance Its Capabilities
From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.
From Rs 43.42 per share (52-week low) to Rs 45.49 per share, the stock is up by 5 per cent.
Pharma Penny Stock Under Rs 50 Jumps Over 10 Per Cent On January 28; PAT Jumps Over 30 Per Cent in Q3FY25
From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
From Rs 43.42 per share (52-week low) to Rs 48.55 per share, the stock is up by 11.8 per cent.
33 Per Cent Jump In PAT: Pharma Penny Stock Under Rs 60 Jumps Over 5 Per Cent On January 23
From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
From Rs 43.35 per share (52-week low) to Rs 51.25 per share, the stock is up by 18.2 per cent.
Pharma Penny Stock Under Rs 60 Jumps After Reporting a 33 Per Cent Jump In PAT
From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent.
From Rs 43.42 per share (52-week low) to Rs 55.66 per share, the stock is up by 28.2 per cent.
Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Pharma Penny Stock Under Rs 60 in Green After Credit Rating Update; Details Inside
From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent.
From Rs 43.42 per share (52-week low) to Rs 51.49 per share, the stock is up by 18.60 per cent.
Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
Pharma stock under Rs 55 in focus as company reports a 38.1 per cent revenue surge & 39.07 per cent jump in PAT
From Rs 43.42 per share (52-week low) to Rs 50.40 per share, the stock is up by 16 per cent.
From Rs 43.42 per share (52-week low) to Rs 50.40 per share, the stock is up by 16 per cent.
Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split!
From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.
From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.
Multibagger pharma stock under Rs 65 is in the green as the company launches its new product lines, PureCoat and UltraMod; Details inside!
From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.
From Rs 35.03 per share (52-week low) to Rs 62.49 per share, the stock is up by 78.4 per cent and gave multibagger returns of 115 per cent in 2 years.
Multibagger pharma stock under Rs 65 to keep under the radar as Board announces cutoff date for final dividend!
From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I
From Rs 33.30 per share (52-week low) to Rs 61.25 per share, the stock is up by 84 per cent and gave multibagger returns of 130 per cent in 2 years. I
Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25)
From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.
From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.